IONIQ Sciences Featured as Innovator at the Forefront in Healthcare Sales & Marketing
IONIQ Sciences is featured in Healthcare Sales & Marketing’s (HS&M) recent issue as an “innovator at the forefront.” HS&M...
Read More
IONIQ Sciences announces its ProLung Test has been formally accepted for submission to China’s National Medical Products Administration
In News
Salt Lake City, UT, September 17, 2020 – IONIQ Sciences, Inc. (“IONIQ” or the “Company”),...
Read More
IONIQ Sciences Named One of Silicon Review’s “50 Smartest Companies of the Year 2020.”
IONIQ Sciences is proud to announce it has been named one of Silicon Review’s “50...
Read More
IONIQ Sciences announces Dr. Ørjan G. Martinsen has joined its Scientific Advisory Committee
In News
Salt Lake City, UT, August 17, 2020 – IONIQ Sciences, Inc. (“IONIQ” or the “Company”),...
Read More
IONIQ Sciences announces Dr. Benjamin Sanchez has joined its Scientific Advisory Committee
In News
Salt Lake City, UT, August 14, 2020 – IONIQ Sciences, Inc. (“IONIQ” or the “Company”),...
Read More
IONIQ ProLung Test™ recognized with Global Innovation & Excellence award for “Best Lung Cancer Detection and Diagnosis Solutions Firm – 2020” by CorporateLiveWire
IONIQ Sciences is delighted to announce its IONIQ ProLung Test™ was recognized with the Global...
Read More
BioUTAH highlights IONIQ Science’s recent accomplishments
Our life sciences industry partner, BioUTAH, published a nice article on their website that highlights...
Read More
IONIQ Sciences announces institutional offering
In News
IONIQ Sciences announces institutional offering Salt Lake City, UT, May 28, 2020 – IONIQ Sciences Inc....
Read More
ProLung announces corporate name change to IONIQ Sciences to reflect expanded early cancer detection strategy
In News
Salt Lake City, UT, May 27, 2020 – IONIQ Sciences Inc. (“IONIQ Sciences” or the...
Read MoreProLung Announces Fully Subscribed Private Placement of $3.3 Million
In News
Salt Lake City, UT, May 22, 2020 – ProLung, Inc. (“ProLung” or the “Company”), which has...
Read More
ProLung, Inc. Called One of the “50 Most Innovative Companies to Watch in 2020” by CEO Views
ProLung, Inc. is proud to announce it is one of the “50 Most Innovative Companies...
Read More
ProLung Test is honored as “Most Innovative Non-Invasive Lung Cancer Testing Solution 2020” by Global Health & Pharma
ProLung has been awarded the “Most Innovative Non-Invasive Lung Cancer Testing Solution 2020” by Global...
Read More